Literature DB >> 29075984

Getting Closer to an Effective Intervention of Ischemic Stroke: The Big Promise of Stem Cell.

Deepaneeta Sarmah1, Harpreet Kaur1, Jackson Saraf1, Kanta Pravalika1, Avirag Goswami2, Kiran Kalia1, Anupom Borah3, Xin Wang4, Kunjan R Dave2, Dileep R Yavagal2, Pallab Bhattacharya5,6.   

Abstract

Stem cell therapy for ischemic stroke has widely been explored. Results from both preclinical and clinical studies have immensely supported the judicious use of stem cells as therapy. These provide an attractive means for preserving and replacing the damaged brain tissues following an ischemic attack. Since the past few years, researchers have used various types of stem cells to replenish insulted neuronal and glial cells in neurological disorders. In the present review, we discuss different types of stem cells employed for the treatment of ischemic stroke and mechanisms and challenges these cells face once introduced into the living system. Further, we also present different ways to maneuver and overcome challenges to translate the advances made at the preclinical level to clinics.

Entities:  

Keywords:  Cell engineering; Clinical; Ischemic stroke; Neuroprotection; Preclinical; Stem cells

Mesh:

Year:  2017        PMID: 29075984     DOI: 10.1007/s12975-017-0580-0

Source DB:  PubMed          Journal:  Transl Stroke Res        ISSN: 1868-4483            Impact factor:   6.829


  240 in total

Review 1.  Creating permissive microenvironments for stem cell transplantation into the central nervous system.

Authors:  Howard Kim; Michael J Cooke; Molly S Shoichet
Journal:  Trends Biotechnol       Date:  2011-08-09       Impact factor: 19.536

2.  Intravenous Injection of Clinical Grade Human MSCs After Experimental Stroke: Functional Benefit and Microvascular Effect.

Authors:  Anack Moisan; Isabelle Favre; Claire Rome; Florence De Fraipont; Emmanuelle Grillon; Nicolas Coquery; Herv Mathieu; Virginie Mayan; Bernadette Naegele; Marc Hommel; Marie-Jeanne Richard; Emmanuel Luc Barbier; Chantal Remy; Olivier Detante
Journal:  Cell Transplant       Date:  2016-02-26       Impact factor: 4.064

3.  Collateral growth and angiogenesis around cortical stroke.

Authors:  L Wei; J P Erinjeri; C M Rovainen; T A Woolsey
Journal:  Stroke       Date:  2001-09       Impact factor: 7.914

Review 4.  Novel Regenerative Therapies Based on Regionally Induced Multipotent Stem Cells in Post-Stroke Brains: Their Origin, Characterization, and Perspective.

Authors:  Toshinori Takagi; Shinichi Yoshimura; Rika Sakuma; Akiko Nakano-Doi; Tomohiro Matsuyama; Takayuki Nakagomi
Journal:  Transl Stroke Res       Date:  2017-07-25       Impact factor: 6.829

5.  Combinated transplantation of neural stem cells and collagen type I promote functional recovery after cerebral ischemia in rats.

Authors:  Hongwei Yu; Bo Cao; Meiyan Feng; Qiang Zhou; Xiaodong Sun; Shuliang Wu; Shizhu Jin; Huiwen Liu; Jin Lianhong
Journal:  Anat Rec (Hoboken)       Date:  2010-05       Impact factor: 2.064

6.  Cord blood rescues stroke-induced changes in splenocyte phenotype and function.

Authors:  Martina Vendrame; Carmelina Gemma; Keith R Pennypacker; Paula C Bickford; Cyndy Davis Sanberg; Paul R Sanberg; Alison E Willing
Journal:  Exp Neurol       Date:  2006-05-19       Impact factor: 5.330

Review 7.  Modification of mesenchymal stem cells for cardiac regeneration.

Authors:  Heesang Song; Byeong-Wook Song; Min-Ji Cha; In-Geol Choi; Ki-Chul Hwang
Journal:  Expert Opin Biol Ther       Date:  2010-03       Impact factor: 4.388

8.  Circulating CD34-positive cells have prognostic value for neurologic function in patients with past cerebral infarction.

Authors:  Akihiko Taguchi; Nami Nakagomi; Tomohiro Matsuyama; Akie Kikuchi-Taura; Hiroo Yoshikawa; Yukiko Kasahara; Haruka Hirose; Hiroshi Moriwaki; Takayuki Nakagomi; Toshihiro Soma; David M Stern; Hiroaki Naritomi
Journal:  J Cereb Blood Flow Metab       Date:  2008-08-13       Impact factor: 6.200

9.  Role of angiogenesis in patients with cerebral ischemic stroke.

Authors:  J Krupinski; J Kaluza; P Kumar; S Kumar; J M Wang
Journal:  Stroke       Date:  1994-09       Impact factor: 7.914

10.  Pre-differentiation of human neural stem cells into GABAergic neurons prior to transplant results in greater repopulation of the damaged brain and accelerates functional recovery after transient ischemic stroke.

Authors:  Hima C S Abeysinghe; Laita Bokhari; Anita Quigley; Mahesh Choolani; Jerry Chan; Gregory J Dusting; Jeremy M Crook; Nao R Kobayashi; Carli L Roulston
Journal:  Stem Cell Res Ther       Date:  2015-09-29       Impact factor: 6.832

View more
  14 in total

1.  Post-stroke Impairment of the Blood-Brain Barrier and Perifocal Vasogenic Edema Is Alleviated by Endovascular Mesenchymal Stem Cell Administration: Modulation of the PKCδ/MMP9/AQP4-Mediated Pathway.

Authors:  Aishika Datta; Deepaneeta Sarmah; Harpreet Kaur; Antra Chaudhary; Kamisetty Leela Mounica; Kiran Kalia; Anupom Borah; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Mol Neurobiol       Date:  2022-02-21       Impact factor: 5.590

2.  Sirtuin-1 - Mediated NF-κB Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis is One of the Neuroprotective Effects of Intra-arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke.

Authors:  Deepaneeta Sarmah; Aishika Datta; Harpreet Kaur; Kiran Kalia; Anupom Borah; Anne Marie Rodriguez; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Stem Cell Rev Rep       Date:  2022-02-03       Impact factor: 5.739

3.  Neural Stem Cell Extracellular Vesicles Disrupt Midline Shift Predictive Outcomes in Porcine Ischemic Stroke Model.

Authors:  Samantha E Spellicy; Erin E Kaiser; Michael M Bowler; Brian J Jurgielewicz; Robin L Webb; Franklin D West; Steven L Stice
Journal:  Transl Stroke Res       Date:  2019-12-06       Impact factor: 6.829

Review 4.  Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials.

Authors:  Zhonghao Li; Xiaoke Dong; Min Tian; Chongchong Liu; Kaiyue Wang; Lili Li; Zunjing Liu; Jinmin Liu
Journal:  Stem Cell Res Ther       Date:  2020-06-26       Impact factor: 6.832

Review 5.  A Friend or Foe: Calcineurin across the Gamut of Neurological Disorders.

Authors:  Jackson Saraf; Pallab Bhattacharya; Kiran Kalia; Anupom Borah; Deepaneeta Sarmah; Harpreet Kaur; Kunjan R Dave; Dileep R Yavagal
Journal:  ACS Cent Sci       Date:  2018-06-27       Impact factor: 14.553

Review 6.  Potential of Exosomes for the Treatment of Stroke.

Authors:  Shi-Bin Hong; Hua Yang; Anatol Manaenko; Jianfei Lu; Qiyong Mei; Qin Hu
Journal:  Cell Transplant       Date:  2018-12-06       Impact factor: 4.064

7.  Association between Non-Alcoholic Fatty Liver Disease and Intracerebral Hemorrhage.

Authors:  Sheng Tu; Ruihong Zhao; Hong Fang; Li Wang; Anwen Shao; Jifang Sheng
Journal:  Cell Transplant       Date:  2019-03-29       Impact factor: 4.064

8.  Transplantation of Directly Reprogrammed Human Neural Precursor Cells Following Stroke Promotes Synaptogenesis and Functional Recovery.

Authors:  Ilan Vonderwalde; Ashkan Azimi; Gabrielle Rolvink; Jan-Eric Ahlfors; Molly S Shoichet; Cindi M Morshead
Journal:  Transl Stroke Res       Date:  2020-02       Impact factor: 6.829

9.  CD133+Exosome Treatment Improves Cardiac Function after Stroke in Type 2 Diabetic Mice.

Authors:  Poornima Venkat; Chengcheng Cui; Zhili Chen; Michael Chopp; Alex Zacharek; Julie Landschoot-Ward; Lauren Culmone; Xiao-Ping Yang; Jiang Xu; Jieli Chen
Journal:  Transl Stroke Res       Date:  2020-03-20       Impact factor: 6.829

Review 10.  Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy.

Authors:  Yinghua Jiang; Ning Liu; Jinrui Han; Yadan Li; Pierce Spencer; Samuel J Vodovoz; Ming-Ming Ning; Gregory Bix; Prasad V G Katakam; Aaron S Dumont; Xiaoying Wang
Journal:  Transl Stroke Res       Date:  2020-11-02       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.